Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA.
North America dominated with respect to revenue generation owing to the presence of significant established participants in this region. Moreover, higher demand for the products for treatment of diseases is attributive for larger revenue share.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Biologics market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Biologics market. Detailed analysis of key players, along with key growth strategies adopted by Biologics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Addgene
Pfizer Inc
Amgen
F Hoffman La Roche
Eli Lilly & Company
Celltrion
Johnson & Johnson Services Inc
Sanofi
Abbvie Inc
Merck & Co Inc
Samsung Biologics
Novo Nordisk A/S
By Type:
Monoclonal Antibodies
Vaccines
Recombinant Proteins
Antisense
RNAi
By End-User:
Infectious Diseases
Oncology
Immunology
Autoimmune Diseases
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biologics Market
-
1.3 Market Segment by Type
-
1.3.1 China Biologics Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
1.3.2 China Biologics Market Size and Growth Rate of Vaccines from 2016 to 2027
-
1.3.3 China Biologics Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027
-
1.3.4 China Biologics Market Size and Growth Rate of Antisense from 2016 to 2027
-
1.3.5 China Biologics Market Size and Growth Rate of RNAi from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Biologics Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
1.4.2 China Biologics Market Size and Growth Rate of Oncology from 2016 to 2027
-
1.4.3 China Biologics Market Size and Growth Rate of Immunology from 2016 to 2027
-
1.4.4 China Biologics Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biologics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biologics by Major Types
-
3.4.1 Market Size and Growth Rate of Monoclonal Antibodies
-
3.4.2 Market Size and Growth Rate of Vaccines
-
3.4.3 Market Size and Growth Rate of Recombinant Proteins
-
3.4.4 Market Size and Growth Rate of Antisense
-
3.4.5 Market Size and Growth Rate of RNAi
4 Segmentation of Biologics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biologics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biologics in Infectious Diseases
-
4.4.2 Market Size and Growth Rate of Biologics in Oncology
-
4.4.3 Market Size and Growth Rate of Biologics in Immunology
-
4.4.4 Market Size and Growth Rate of Biologics in Autoimmune Diseases
5 Market Analysis by Regions
-
5.1 China Biologics Production Analysis by Regions
-
5.2 China Biologics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Biologics Landscape Analysis
-
6.1 North China Biologics Landscape Analysis by Major Types
-
6.2 North China Biologics Landscape Analysis by Major End-Users
7 Central China Biologics Landscape Analysis
-
7.1 Central China Biologics Landscape Analysis by Major Types
-
7.2 Central China Biologics Landscape Analysis by Major End-Users
8 South China Biologics Landscape Analysis
-
8.1 South China Biologics Landscape Analysis by Major Types
-
8.2 South China Biologics Landscape Analysis by Major End-Users
9 East China Biologics Landscape Analysis
-
9.1 East China Biologics Landscape Analysis by Major Types
-
9.2 East China Biologics Landscape Analysis by Major End-Users
10 Northeast China Biologics Landscape Analysis
-
10.1 Northeast China Biologics Landscape Analysis by Major Types
-
10.2 Northeast China Biologics Landscape Analysis by Major End-Users
11 Southwest China Biologics Landscape Analysis
-
11.1 Southwest China Biologics Landscape Analysis by Major Types
-
11.2 Southwest China Biologics Landscape Analysis by Major End-Users
12 Northwest China Biologics Landscape Analysis
-
12.1 Northwest China Biologics Landscape Analysis by Major Types
-
12.2 Northwest China Biologics Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Addgene
-
13.1.1 Addgene Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Pfizer Inc
-
13.2.1 Pfizer Inc Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Amgen
-
13.3.1 Amgen Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 F Hoffman La Roche
-
13.4.1 F Hoffman La Roche Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Eli Lilly & Company
-
13.5.1 Eli Lilly & Company Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Celltrion
-
13.6.1 Celltrion Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Johnson & Johnson Services Inc
-
13.7.1 Johnson & Johnson Services Inc Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Sanofi
-
13.8.1 Sanofi Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Abbvie Inc
-
13.9.1 Abbvie Inc Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Merck & Co Inc
-
13.10.1 Merck & Co Inc Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Samsung Biologics
-
13.11.1 Samsung Biologics Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Novo Nordisk A/S
-
13.12.1 Novo Nordisk A/S Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Biologics Market Size and Growth Rate of Monoclonal Antibodies from 2016 to 2027
-
Figure China Biologics Market Size and Growth Rate of Vaccines from 2016 to 2027
-
Figure China Biologics Market Size and Growth Rate of Recombinant Proteins from 2016 to 2027
-
Figure China Biologics Market Size and Growth Rate of Antisense from 2016 to 2027
-
Figure China Biologics Market Size and Growth Rate of RNAi from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Biologics Market Size and Growth Rate of Infectious Diseases from 2016 to 2027
-
Figure China Biologics Market Size and Growth Rate of Oncology from 2016 to 2027
-
Figure China Biologics Market Size and Growth Rate of Immunology from 2016 to 2027
-
Figure China Biologics Market Size and Growth Rate of Autoimmune Diseases from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Biologics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biologics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biologics
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biologics by Different Types from 2016 to 2027
-
Table Consumption Share of Biologics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Monoclonal Antibodies
-
Figure Market Size and Growth Rate of Vaccines
-
Figure Market Size and Growth Rate of Recombinant Proteins
-
Figure Market Size and Growth Rate of Antisense
-
Figure Market Size and Growth Rate of RNAi
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biologics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biologics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Infectious Diseases
-
Figure Market Size and Growth Rate of Oncology
-
Figure Market Size and Growth Rate of Immunology
-
Figure Market Size and Growth Rate of Autoimmune Diseases
-
Table China Biologics Production by Regions
-
Table China Biologics Production Share by Regions
-
Figure China Biologics Production Share by Regions in 2016
-
Figure China Biologics Production Share by Regions in 2021
-
Figure China Biologics Production Share by Regions in 2027
-
Table China Biologics Consumption by Regions
-
Table China Biologics Consumption Share by Regions
-
Figure China Biologics Consumption Share by Regions in 2016
-
Figure China Biologics Consumption Share by Regions in 2021
-
Figure China Biologics Consumption Share by Regions in 2027
-
Table North China Biologics Consumption by Types from 2016 to 2027
-
Table North China Biologics Consumption Share by Types from 2016 to 2027
-
Figure North China Biologics Consumption Share by Types in 2016
-
Figure North China Biologics Consumption Share by Types in 2021
-
Figure North China Biologics Consumption Share by Types in 2027
-
Table North China Biologics Consumption by End-Users from 2016 to 2027
-
Table North China Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure North China Biologics Consumption Share by End-Users in 2016
-
Figure North China Biologics Consumption Share by End-Users in 2021
-
Figure North China Biologics Consumption Share by End-Users in 2027
-
Table Central China Biologics Consumption by Types from 2016 to 2027
-
Table Central China Biologics Consumption Share by Types from 2016 to 2027
-
Figure Central China Biologics Consumption Share by Types in 2016
-
Figure Central China Biologics Consumption Share by Types in 2021
-
Figure Central China Biologics Consumption Share by Types in 2027
-
Table Central China Biologics Consumption by End-Users from 2016 to 2027
-
Table Central China Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Biologics Consumption Share by End-Users in 2016
-
Figure Central China Biologics Consumption Share by End-Users in 2021
-
Figure Central China Biologics Consumption Share by End-Users in 2027
-
Table South China Biologics Consumption by Types from 2016 to 2027
-
Table South China Biologics Consumption Share by Types from 2016 to 2027
-
Figure South China Biologics Consumption Share by Types in 2016
-
Figure South China Biologics Consumption Share by Types in 2021
-
Figure South China Biologics Consumption Share by Types in 2027
-
Table South China Biologics Consumption by End-Users from 2016 to 2027
-
Table South China Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure South China Biologics Consumption Share by End-Users in 2016
-
Figure South China Biologics Consumption Share by End-Users in 2021
-
Figure South China Biologics Consumption Share by End-Users in 2027
-
Table East China Biologics Consumption by Types from 2016 to 2027
-
Table East China Biologics Consumption Share by Types from 2016 to 2027
-
Figure East China Biologics Consumption Share by Types in 2016
-
Figure East China Biologics Consumption Share by Types in 2021
-
Figure East China Biologics Consumption Share by Types in 2027
-
Table East China Biologics Consumption by End-Users from 2016 to 2027
-
Table East China Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure East China Biologics Consumption Share by End-Users in 2016
-
Figure East China Biologics Consumption Share by End-Users in 2021
-
Figure East China Biologics Consumption Share by End-Users in 2027
-
Table Northeast China Biologics Consumption by Types from 2016 to 2027
-
Table Northeast China Biologics Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Biologics Consumption Share by Types in 2016
-
Figure Northeast China Biologics Consumption Share by Types in 2021
-
Figure Northeast China Biologics Consumption Share by Types in 2027
-
Table Northeast China Biologics Consumption by End-Users from 2016 to 2027
-
Table Northeast China Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Biologics Consumption Share by End-Users in 2016
-
Figure Northeast China Biologics Consumption Share by End-Users in 2021
-
Figure Northeast China Biologics Consumption Share by End-Users in 2027
-
Table Southwest China Biologics Consumption by Types from 2016 to 2027
-
Table Southwest China Biologics Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Biologics Consumption Share by Types in 2016
-
Figure Southwest China Biologics Consumption Share by Types in 2021
-
Figure Southwest China Biologics Consumption Share by Types in 2027
-
Table Southwest China Biologics Consumption by End-Users from 2016 to 2027
-
Table Southwest China Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Biologics Consumption Share by End-Users in 2016
-
Figure Southwest China Biologics Consumption Share by End-Users in 2021
-
Figure Southwest China Biologics Consumption Share by End-Users in 2027
-
Table Northwest China Biologics Consumption by Types from 2016 to 2027
-
Table Northwest China Biologics Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Biologics Consumption Share by Types in 2016
-
Figure Northwest China Biologics Consumption Share by Types in 2021
-
Figure Northwest China Biologics Consumption Share by Types in 2027
-
Table Northwest China Biologics Consumption by End-Users from 2016 to 2027
-
Table Northwest China Biologics Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Biologics Consumption Share by End-Users in 2016
-
Figure Northwest China Biologics Consumption Share by End-Users in 2021
-
Figure Northwest China Biologics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Addgene
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Addgene
-
Figure Sales and Growth Rate Analysis of Addgene
-
Figure Revenue and Market Share Analysis of Addgene
-
Table Product and Service Introduction of Addgene
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of F Hoffman La Roche
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of F Hoffman La Roche
-
Figure Sales and Growth Rate Analysis of F Hoffman La Roche
-
Figure Revenue and Market Share Analysis of F Hoffman La Roche
-
Table Product and Service Introduction of F Hoffman La Roche
-
Table Company Profile and Development Status of Eli Lilly & Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly & Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly & Company
-
Figure Revenue and Market Share Analysis of Eli Lilly & Company
-
Table Product and Service Introduction of Eli Lilly & Company
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
Table Company Profile and Development Status of Johnson & Johnson Services Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson Services Inc
-
Figure Sales and Growth Rate Analysis of Johnson & Johnson Services Inc
-
Figure Revenue and Market Share Analysis of Johnson & Johnson Services Inc
-
Table Product and Service Introduction of Johnson & Johnson Services Inc
-
Table Company Profile and Development Status of Sanofi
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi
-
Figure Sales and Growth Rate Analysis of Sanofi
-
Figure Revenue and Market Share Analysis of Sanofi
-
Table Product and Service Introduction of Sanofi
-
Table Company Profile and Development Status of Abbvie Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Abbvie Inc
-
Figure Sales and Growth Rate Analysis of Abbvie Inc
-
Figure Revenue and Market Share Analysis of Abbvie Inc
-
Table Product and Service Introduction of Abbvie Inc
-
Table Company Profile and Development Status of Merck & Co Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck & Co Inc
-
Figure Sales and Growth Rate Analysis of Merck & Co Inc
-
Figure Revenue and Market Share Analysis of Merck & Co Inc
-
Table Product and Service Introduction of Merck & Co Inc
-
Table Company Profile and Development Status of Samsung Biologics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Samsung Biologics
-
Figure Sales and Growth Rate Analysis of Samsung Biologics
-
Figure Revenue and Market Share Analysis of Samsung Biologics
-
Table Product and Service Introduction of Samsung Biologics
-
Table Company Profile and Development Status of Novo Nordisk A/S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novo Nordisk A/S
-
Figure Sales and Growth Rate Analysis of Novo Nordisk A/S
-
Figure Revenue and Market Share Analysis of Novo Nordisk A/S
-
Table Product and Service Introduction of Novo Nordisk A/S
-
